belantamab mafodotin-blmf 70 MG Injection
- RxCUI
- 2725585
- RxNorm name
- belantamab mafodotin-blmf 70 MG Injection
- Display name
- belantamab mafodotin-blmf 70 MG Injection
- Full name
- belantamab mafodotin-blmf 70 MG Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761440 | Blenrep | belantamab mafodotin-blmf | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Blenrep | BELANTAMAB MAFODOTIN | GlaxoSmithKline LLC | aef7c34c-fef8-407c-99c0-a68aded53c60 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | 2725585 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| aef7c34c-fef8-407c-99c0-a68aded53c60 | belantamab mafodotin-blmf 70 MG Injection [PSN] · belantamab mafodotin-blmf 70 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BLENREP safely and effectively. See full prescribing information for BLENREP. BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use Initial U.S. Approval: 2020 | 20251023 |